Kavanagh PV
Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin 8, Ireland.
ArticleLSD
Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).
ArticleLSD
Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD).
ArticleLSD
Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD).
ArticleLSD
Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N<sup>6</sup> -ethylnorlysergic acid N,N-diethylamide (ETH-LAD).
ArticleLSD
Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities.
ArticlePsilocybin
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.
ArticleLSD
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD).
ArticleMDMA
(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.
ArticleLSD
Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ).
ArticleLSD
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
ArticleLSD
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
ArticleLSD